Klaria Pharma Holding AB (publ) calls an Extraordinary General Meeting to resolve on a Rights Issue of units and an amendment of the Articles of Association
Klaria Pharma Holding AB has convened an Extraordinary General Meeting to propose a rights issue of up to 61.5 million units, aiming to raise approximately SEK 148 million before issue costs. The subscription price is set at 2.40 SEK per unit, representing a 26% discount to the theoretical ex-rights price, with non-participating shareholders facing potential dilution of up to 56%.
Key figures
- Proceeds sek
- 148 million
- Max dilution percent
- 56
- Discount to terp percent
- 26
- Subscription commitments sek
- 40 million
- Warrant potential proceeds sek
- 37 million
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.